EMEA-001809-PIP01-15-M01
Key facts
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0173/2019
|
PIP number |
EMEA-001809-PIP01-15-M01
|
Pharmaceutical form(s) |
Powder for solution for infusion
|
Condition(s) / indication(s) |
Treatment of Gram-negative bacterial infections
|
Route(s) of administration |
Parenteral use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Belgium |
Decision type |
PM: decision on the application for modification of an agreed PIP
|